Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.57 and traded as low as $0.4056. Elite Pharmaceuticals shares last traded at $0.4456, with a volume of 490,676 shares trading hands.
Elite Pharmaceuticals Price Performance
The company has a current ratio of 8.04, a quick ratio of 6.34 and a debt-to-equity ratio of 0.06. The company has a market cap of $479.91 million, a P/E ratio of 44.60 and a beta of 0.32. The business’s fifty day moving average is $0.49 and its 200 day moving average is $0.57.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
See Also
- Five stocks we like better than Elite Pharmaceuticals
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
